# ClinicalTrials.gov record NCT04775082

> PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct04775082-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-09
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04775082-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04775082-liraglutide-v1.json
- Content SHA-256: `df48c368b42f28409cec6a146cbc2377630892ace7932551be2850206b763f64`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04775082 ([`ctg-observation-nct04775082-2026-07-09-b565460c570f`](#source-ctg-observation-nct04775082-2026-07-09-b565460c570f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct04775082-2026-07-09-b565460c570f`](#source-ctg-observation-nct04775082-2026-07-09-b565460c570f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct04775082-2026-07-09-b565460c570f`](#source-ctg-observation-nct04775082-2026-07-09-b565460c570f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04775082-2026-07-09-b565460c570f`](#source-ctg-observation-nct04775082-2026-07-09-b565460c570f))

## Sources

<a id="source-ctg-observation-nct04775082-2026-07-09-b565460c570f"></a>
- **ClinicalTrials.gov record NCT04775082 · retained source version 2026-07-09:b565460c570f54691038370a4ed8849b5613367537a68460b01624478cd31cfe** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04775082) (`ctg-observation-nct04775082-2026-07-09-b565460c570f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04775082." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04775082-liraglutide-v1.json SHA-256: df48c368b42f28409cec6a146cbc2377630892ace7932551be2850206b763f64.